Home
ALLK
ALLK News

Latest Allakos Inc. (ALLK) News on February 23, 2025

BioAge drops obesity drug; Akero, 89bio cash in on MASH data

BioPharma Dive

25 days ago

BioAge drops obesity drug; Akero, 89bio cash in on MASH data

Allakos cuts 75% of workforce after chronic hives trial failure

Pharmaceutical Technology

a month ago

Allakos cuts 75% of workforce after chronic hives trial failure

MT Newswires

a month ago

Top Midday Decliners

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires

a month ago

Allakos to Discontinue Development of Urticaria Treatment, Cut Staff; Shares Fall

Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring

GlobeNewswire

a month ago

Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring

Discover US Penny Stocks To Watch In January 2025

Simply Wall St.

a month ago

Discover US Penny Stocks To Watch In January 2025

3 US Penny Stocks Under $200M Market Cap To Watch

Simply Wall St.

3 months ago

3 US Penny Stocks Under $200M Market Cap To Watch

All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy

Zacks

3 months ago

All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy

Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire

4 months ago

Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results

3 US Penny Stocks With Market Caps Larger Than $50M

Simply Wall St.

4 months ago

3 US Penny Stocks With Market Caps Larger Than $50M

MT Newswires

4 months ago

Allakos Subcutaneous Therapy for Mast Cells-Related Diseases 'Well-Tolerated;' Shares Up After Hours

Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers

GlobeNewswire

4 months ago

Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers

MT Newswires

6 months ago

Allakos Gets Nasdaq Noncompliance Notice on Minimum Bid Price

Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire

7 months ago

Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results

Can Allakos (NASDAQ:ALLK) Afford To Invest In Growth?

Simply Wall St.

7 months ago

Can Allakos (NASDAQ:ALLK) Afford To Invest In Growth?

MT Newswires

8 months ago

Allakos Reports 'Positive' Results From Phase 1 Trial of Antibody That Inhibits Mast Cells

GlobeNewswire

8 months ago

Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

8 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

8 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

8 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

8 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

8 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

8 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

8 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

8 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

8 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

8 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

8 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

8 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

8 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

8 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

8 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

8 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria

GlobeNewswire

9 months ago

Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria

GuruFocus.com

9 months ago

Allakos Inc. Reports Increased Losses in Q1 2024, Misses Analyst Earnings Predictions

Allakos Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire

9 months ago

Allakos Provides Business Update and Reports First Quarter 2024 Financial Results

With 55% ownership of the shares, Allakos Inc. (NASDAQ:ALLK) is heavily dominated by institutional owners

Simply Wall St.

10 months ago

With 55% ownership of the shares, Allakos Inc. (NASDAQ:ALLK) is heavily dominated by institutional owners

Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions

Zacks

a year ago

Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions

GuruFocus.com

a year ago

Allakos Inc (ALLK) Reports Increased R&D Expenses and Net Loss in Q4

Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

a year ago

Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024

GlobeNewswire

a year ago

Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024

Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition

GlobeNewswire

a year ago

Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition

VIZSLA SILVER ADDS UNPARALLELED MINE-BUILDING AND OPERATING EXPERTISE, APPOINTS SIMON CMRLEC TO THE ROLE OF COO

CNW Group

a year ago

VIZSLA SILVER ADDS UNPARALLELED MINE-BUILDING AND OPERATING EXPERTISE, APPOINTS SIMON CMRLEC TO THE ROLE OF COO

Investar Holding Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Investar Holding Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Middlefield Banc Corp. Reports 2023 Full-Year Financial Results

GlobeNewswire

a year ago

Middlefield Banc Corp. Reports 2023 Full-Year Financial Results

EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 16,386 Shares

GuruFocus.com

a year ago

EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 16,386 Shares

EGain (EGAN) Rises Higher Than Market: Key Facts

Zacks

a year ago

EGain (EGAN) Rises Higher Than Market: Key Facts

LuxUrban Hotels Inc. (NASDAQ:LUXH) Has Found A Path To Profitability

Simply Wall St.

a year ago

LuxUrban Hotels Inc. (NASDAQ:LUXH) Has Found A Path To Profitability

Industrial Logistics Properties Trust's Dividend Analysis

GuruFocus.com

a year ago

Industrial Logistics Properties Trust's Dividend Analysis

Should You Buy Small Cap Stocks Right Now?

Zacks

a year ago

Should You Buy Small Cap Stocks Right Now?

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Zacks

a year ago

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Here's Why Allakos Inc. (ALLK) is Poised for a Turnaround After Losing -61.36% in 4 Weeks

Zacks

a year ago

Here's Why Allakos Inc. (ALLK) is Poised for a Turnaround After Losing -61.36% in 4 Weeks

ARMOUR Residential REIT, Inc. (ARR) is Attracting Investor Attention: Here is What You Should Know

Zacks

a year ago

ARMOUR Residential REIT, Inc. (ARR) is Attracting Investor Attention: Here is What You Should Know

Small-Cap Surprises: 7 Undiscovered Growth Stocks Poised to Explode

InvestorPlace

a year ago

Small-Cap Surprises: 7 Undiscovered Growth Stocks Poised to Explode

Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug

Zacks

a year ago

Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug

Is Allakos (ALLK) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Allakos (ALLK) Stock Outpacing Its Medical Peers This Year?

Reuters

a year ago

UPDATE 2-Allakos tumbles after skin disease drug fails mid-stage studies

Reuters

a year ago

Allakos says experimental skin disease drug fails mid-stage studies

Allakos Announces a Restructuring to Focus on Development of AK006

GlobeNewswire

a year ago

Allakos Announces a Restructuring to Focus on Development of AK006

Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints

GlobeNewswire

a year ago

Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints

Does the Market Have Doubts About Gray Television’s (GTN) Future?

Insider Monkey

a year ago

Does the Market Have Doubts About Gray Television’s (GTN) Future?

Piedmont Lithium Inc. (PLL) Stock Sinks As Market Gains: What You Should Know

Zacks

a year ago

Piedmont Lithium Inc. (PLL) Stock Sinks As Market Gains: What You Should Know

Rigel Pharmaceuticals Provides Business Update

PR Newswire

a year ago

Rigel Pharmaceuticals Provides Business Update

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

PR Newswire

a year ago

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

a year ago

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

GlobeNewswire

a year ago

XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus

Here's Why We Think Concrete Pumping Holdings (NASDAQ:BBCP) Is Well Worth Watching

Simply Wall St.

a year ago

Here's Why We Think Concrete Pumping Holdings (NASDAQ:BBCP) Is Well Worth Watching

Upland Software Secures 40+ Badges in G2’s Winter 2024 Market Reports

Business Wire

a year ago

Upland Software Secures 40+ Badges in G2’s Winter 2024 Market Reports

Is Now The Time To Put X Financial (NYSE:XYF) On Your Watchlist?

Simply Wall St.

a year ago

Is Now The Time To Put X Financial (NYSE:XYF) On Your Watchlist?

Forge Global Announces First-of-its-Kind Investable Private Market Index in Partnership with Accuidity to Provide Diversified Exposure to Late Stage Companies

Business Wire

a year ago

Forge Global Announces First-of-its-Kind Investable Private Market Index in Partnership with Accuidity to Provide Diversified Exposure to Late Stage Companies

Newegg Regains Compliance with Nasdaq Minimum Bid Requirements

Business Wire

a year ago

Newegg Regains Compliance with Nasdaq Minimum Bid Requirements

Pleasing Signs As A Number Of Insiders Buy NexPoint Real Estate Finance Stock

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy NexPoint Real Estate Finance Stock

Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study

Zacks

a year ago

Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study

Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth

Simply Wall St.

a year ago

Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth

El Pollo Loco Holdings, Inc. Announces $12.6 Million Repurchase Agreement

GlobeNewswire

a year ago

El Pollo Loco Holdings, Inc. Announces $12.6 Million Repurchase Agreement

The past five years for Primis Financial (NASDAQ:FRST) investors has not been profitable

Simply Wall St.

a year ago

The past five years for Primis Financial (NASDAQ:FRST) investors has not been profitable

4 Best Breakout Stocks to Invest in for Solid Returns

Zacks

a year ago

4 Best Breakout Stocks to Invest in for Solid Returns

ParkOhio Announces Ratings Upgrade from Moody’s

Business Wire

a year ago

ParkOhio Announces Ratings Upgrade from Moody’s

Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis

GlobeNewswire

a year ago

Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis

Materialise NV's (NASDAQ:MTLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Simply Wall St.

a year ago

Materialise NV's (NASDAQ:MTLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why

Zacks

a year ago

Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why

Read This Before Considering SunCoke Energy, Inc. (NYSE:SXC) For Its Upcoming US$0.10 Dividend

Simply Wall St.

a year ago

Read This Before Considering SunCoke Energy, Inc. (NYSE:SXC) For Its Upcoming US$0.10 Dividend

Be Sure To Check Out Greene County Bancorp, Inc. (NASDAQ:GCBC) Before It Goes Ex-Dividend

Simply Wall St.

a year ago

Be Sure To Check Out Greene County Bancorp, Inc. (NASDAQ:GCBC) Before It Goes Ex-Dividend

Does Hippo Holdings Inc. (HIPO) Have the Potential to Rally 132.62% as Wall Street Analysts Expect?

Zacks

a year ago

Does Hippo Holdings Inc. (HIPO) Have the Potential to Rally 132.62% as Wall Street Analysts Expect?

Thomson Reuters StreetEvents

a year ago

Q3 2023 InfuSystem Holdings Inc Earnings Call

InfuSystem Holdings Inc (INFU) Reports 17% Growth in Q3 2023 Net Revenues, Net Income Increases ...

GuruFocus.com

a year ago

InfuSystem Holdings Inc (INFU) Reports 17% Growth in Q3 2023 Net Revenues, Net Income Increases ...

Associated Press Finance

a year ago

Hallador Energy: Q3 Earnings Snapshot

Mistras Group, Inc. (NYSE:MG) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Mistras Group, Inc. (NYSE:MG) Q3 2023 Earnings Call Transcript

Share on Social Networks: